Skip to main content
Premium Trial:

Request an Annual Quote

Bayer, RWTH Aachen University Create Computational Biomedicine Center

NEW YORK (GenomeWeb News) – Bayer Technology Services today said it and RWTH Aachen University in Germany have collaborated to form the Joint Research Center on Computational Biomedicine.

A component of the Research Cluster for Modeling and Simulation and the Faculty of Medicine at the university, the center's goal is to develop new methods in computer-based modeling of complex biological processes, BTS, a subsidiary of Bayer, said.

Andreas Schuppert, an expert in industrial mathematics at BTS and a professor at Aachen Institute for Advanced Study in Computational Engineering Science, RWTH Aachen University, will head the center with a professor still to be appointed. The center will have an initial staff of 10.

Wolfgang Plischke, a member of the Bayer Board of Management responsible for Technology, Innovation, and Sustainability, said in a statement that insight into the molecular mechanisms in biology is "of high strategic relevance for our life science units."

Stefan Uhlig, dean of the Faculty of Medicine at the university and a member of the board of the University Hospital RWTH Aachen, added, "Without computers we shall never fully understand diseases or climate changes. The complexity is simply too big. This research will not only help to shed light on fundamental physiological processes, it will also help us to better understand a multitude of diseases. This, in turn, enables new active ingredients to be developed more quickly and to be used more precisely during a course of treatment."

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.